Atlas Trials

Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).

Clinical trial NCT02909088 · UNKNOWN

Trial details

NCT number
NCT02909088
Sponsor
Gerald Maguire, MD
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Stuttering, AdultChildhood-onset Fluency DisorderSpeech DisordersLanguage DisordersCommunication Disorder
Start date
2016-09-01
Primary completion
2017-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.